Rafael (RFL) vs Stablecoin Development (SDEV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Rafael (RFL) has outperformed Stablecoin Development (SDEV) over the past year, gaining 20.3% versus a loss of 76.1%. Over five years, RFL leads with a -94.7% price change compared with -100.0% for SDEV. Rafael is the larger company by market cap ($83.2 million vs $79.7 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | RFL | SDEV |
|---|---|---|
| Share price | $1.60 | $1.54 |
| Market cap | $83.20M | $79.70M |
| 1-day change | +8.11% | -22.61% |
| YTD return | +35.59% | -94.54% |
| 1-year return | +20.30% | -76.12% |
| 5-year return | -94.69% | -99.95% |
| EPS (TTM) | $-0.72 | $-21.13 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.96 | $99.75 |
| 52-week low | $1.12 | $0.78 |
| Distance from 52-week high | -59.60% | -98.46% |
| Average volume | 159.35K | 11.99M |
| Shares outstanding | 51.21M | 51.75M |
| Employees | 21 | 2 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RFL has outperformed SDEV by 96.4 percentage points over the past year.
About Rafael
RFL stock →Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and medical devices in the United States and Israel.
Health Care · Biotechnology: Pharmaceutical Preparations · 21 employees
About Stablecoin Development
SDEV stock →Stablecoin Development Corporation engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
RFL vs SDEV FAQ
Which is bigger, Rafael or Stablecoin Development?
Rafael (RFL) is larger, with a market capitalization of $83.20M compared with $79.70M for Stablecoin Development (SDEV).
Which stock has performed better over the past year, RFL or SDEV?
RFL returned +20.30% over the past 12 months, compared with -76.12% for SDEV (price return, excluding dividends). Past performance does not predict future results.
Are Rafael and Stablecoin Development in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.